BlackRock Updates Elevance Health Stake in SC 13G/A Filing
Ticker: ELV · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 1156039
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, healthcare, passive-investment
TL;DR
**BlackRock just updated its Elevance Health stake, signaling its latest position.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on February 12, 2024, indicating its ownership of Elevance Health, Inc. (formerly Anthem, Inc.) common stock as of December 31, 2023. This filing, Amendment No. 14, updates their previous disclosures regarding their stake in the healthcare company. This matters to investors because BlackRock is a major institutional investor, and changes in their reported holdings can signal shifts in their investment strategy or outlook on Elevance Health's future performance.
Why It Matters
This filing shows BlackRock's continued significant, though potentially adjusted, investment in Elevance Health, which can influence market perception and investor confidence.
Risk Assessment
Risk Level: low — This is a routine disclosure filing by a large institutional investor and does not inherently indicate a high level of risk.
Analyst Insight
Investors should note BlackRock's continued presence as a significant shareholder in Elevance Health, but this filing alone doesn't provide enough detail to infer a specific bullish or bearish action. Further analysis of BlackRock's full 13F filing (when available) would be needed to see the exact change in share count.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Elevance Health, Inc. (company) — the subject company whose common stock is being reported
- Anthem, Inc. (company) — former name of Elevance Health, Inc.
- December 31, 2023 (date) — the date of the event which required the filing
- February 12, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 14)' sections.
Who is the reporting person in this filing?
The reporting person, or the entity that filed this document, is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What company's securities are being reported on?
The securities being reported on belong to Elevance Health, Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc.' and 'Elevance Health, Inc. (Name of Issuer)'.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement)'.
Under which SEC rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 12, 2024 regarding Elevance Health, Inc. (ELV).